tiopronin has been researched along with Hepatitis B, Chronic in 2 studies
Tiopronin: Sulfhydryl acylated derivative of GLYCINE.
Hepatitis B, Chronic: INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hepatotoxicity induced by sorafenib and antiviral therapy is a limitation for its continuation treatment for patients with advanced hepatitis B virus-related hepatocellular carcinoma (HCC)." | 9.20 | Prospective analysis of tiopronin in prevention of sorafenib and antiviral therapy inducing liver toxicity in advanced hepatitis B virus-related hepatocellular carcinoma. ( Guo, W; Li, J; Qiu, X; Yan, B; Zhang, S, 2015) |
| "To observe the clearance effect of Tiopronin on oxygen free radicals in chronic hepatitis B patients." | 9.09 | [A preliminary study on the activation of superoxide dismutase by Tiopronin in patients with chronic hepatitis B]. ( Chen, C; Qiu, S; Tan, Z, 2000) |
| "Hepatotoxicity induced by sorafenib and antiviral therapy is a limitation for its continuation treatment for patients with advanced hepatitis B virus-related hepatocellular carcinoma (HCC)." | 5.20 | Prospective analysis of tiopronin in prevention of sorafenib and antiviral therapy inducing liver toxicity in advanced hepatitis B virus-related hepatocellular carcinoma. ( Guo, W; Li, J; Qiu, X; Yan, B; Zhang, S, 2015) |
| "To observe the clearance effect of Tiopronin on oxygen free radicals in chronic hepatitis B patients." | 5.09 | [A preliminary study on the activation of superoxide dismutase by Tiopronin in patients with chronic hepatitis B]. ( Chen, C; Qiu, S; Tan, Z, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J | 1 |
| Qiu, X | 1 |
| Guo, W | 1 |
| Yan, B | 1 |
| Zhang, S | 1 |
| Chen, C | 1 |
| Tan, Z | 1 |
| Qiu, S | 1 |
2 trials available for tiopronin and Hepatitis B, Chronic
| Article | Year |
|---|---|
Prospective analysis of tiopronin in prevention of sorafenib and antiviral therapy inducing liver toxicity in advanced hepatitis B virus-related hepatocellular carcinoma.
Topics: Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Femal | 2015 |
[A preliminary study on the activation of superoxide dismutase by Tiopronin in patients with chronic hepatitis B].
Topics: Adult; Alanine Transaminase; Bilirubin; Blood Proteins; Female; Free Radical Scavengers; Hepatitis B | 2000 |